TCT-900 Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

David Erlinge(Lund University), Moman A. Mohammad(Lund University), Ole Fröbert(Aarhus University), Sacharias von Koch(Skåne University Hospital), Matthias Götberg, Jonas Andersson(Skellefteå Hospital), Stefan James(Uppsala University Hospital)

Journal of the American College of Cardiology

October 1, 2025

10.1016/j.jacc.2025.09.1083

Cited by 0

Related Papers

Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest

|New England Journal of Medicine|2013|2.8k

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

|European Heart Journal|2021|1.7k

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest

|New England Journal of Medicine|2021|979

Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

|European Heart Journal|2019|897

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

|European Heart Journal|2007|457